Expand IOVA Menu
IOVA MENU

IOVA Stock Summary and Trading Ideas (Iovance Biotherapeutics | NASDAQ:IOVA)

Charts for Today's Stock Price and Implied Volatility in Iovance Biotherapeutics

27-Feb-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for IOVA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Iovance Biotherapeutics (IOVA) Frequently Asked Questions

What does Iovance Biotherapeutics do?

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

What symbol and exchange does Iovance Biotherapeutics shares trade?

Iovance Biotherapeutics trades on the NASDAQ stock market under the symbol IOVA.

What is Iovance Biotherapeutics stock price doing today?

As of February 27, 2026, IOVA stock price climbed to $3.86 with 18,191,175 million shares trading.

What is Iovance Biotherapeutics's Beta?

IOVA has a beta of 1.71, meaning it tends to be more sensitive to market movements. IOVA has a correlation of 0.06 to the broad based SPY ETF.

How much is Iovance Biotherapeutics worth?

IOVA has a market cap of $1.40 billion. This is considered a Small Cap stock.

How much money does Iovance Biotherapeutics make?

Last quarter Iovance Biotherapeutics reported $87 million in Revenue and -$.18 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.01.

What is the highest and lowest price Iovance Biotherapeutics traded in the last 3 year period?

In the last 3 years, IOVA traded as high as $18.33 and as low as $1.64.

What are the top ETFs holding Iovance Biotherapeutics?

The top ETF exchange traded funds that IOVA belongs to (by Net Assets): XBI, VTI, IWM, VB, IWN.

Is Iovance Biotherapeutics (IOVA) a good investment?

IOVA has underperformed the market in the last year with a return of -26.6%, while SPY returned +18.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IOVA shares. However, IOVA has outperformed the market in the last 3 month and 2 week periods, returning +58.2% and +50.2%, while SPY returned +1.2% and +0.6%, respectively. This indicates IOVA has been having a stronger performance recently.

What are the support and resistance levels for Iovance Biotherapeutics (IOVA)?

IOVA support price is $3.56 and resistance is $4.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IOVA shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes